Which has the lower trailing P/E, MELI or OSCR?

OSCR has the lower trailing P/E: MELI trades at 49.75 and OSCR at 21.99. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, MELI or OSCR?

Over the past five years, OSCR grew revenue faster — MELI at a 44.82% CAGR versus OSCR at 64.83%.

Is MELI or OSCR more profitable?

MELI runs the higher net margin — MELI at 5.30% versus OSCR at 3.60%.

How have MELI and OSCR total returns compared?

Over the past 5 years, MELI delivered 26.94% and OSCR delivered 15.93% annualized total return. Past performance doesn't predict future results.

MercadoLibre, Inc. (MELI) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of MercadoLibre, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 14, 2026. Differences are shown without an overall score or investment verdict.

Different business models: MELI is classified in Consumer Cyclical; OSCR is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

MELI

MercadoLibre, Inc.

$93.52B

$1,844.58Consumer CyclicalDelayed quote: Aug 14, 2026, 4:00 PM EDT

OSCR

Oscar Health, Inc.

$8.49B

$32.76HealthcareDelayed quote: Aug 14, 2026, 4:00 PM EDT

Total return — MELI vs OSCR

growth of $100 · dividends reinvested · last 5y

MELI +11.6% (+2.2%/yr)OSCR -11.6% (-2.4%/yr)MELI compounded faster over this window

MELI OSCR

MELI vs OSCR: by the numbers

•MELI is the larger company ($93.52B vs $8.49B market cap).
•OSCR trades at the lower trailing earnings multiple (21.99 vs 49.75 P/E), one valuation lens rather than an overall verdict.
•MELI converts more revenue to profit (5.30% vs 3.60% net margin).
•OSCR grew revenue faster over the past five years (64.83% vs 44.82% CAGR).

Metrics side by side

Valuation

Metric	MELI	OSCR
P/E ratio	49.75	21.99
Forward P/E	47.52	27.88
P/S ratio	2.63	0.67
P/B ratio	11.83	5.00
EV / EBITDA	26.26	10.15
FCF yield	13.44%	42.19%

Profitability

Metric	MELI	OSCR
Gross margin	42.68%	14.38%
Operating margin	8.26%	4.07%
Net margin	5.30%	3.60%
ROE	23.78%	26.84%
ROIC	11.78%	N/A

Growth (annualized)

Metric	MELI	OSCR
Revenue CAGR (5Y)	44.82%	64.83%
FCF CAGR (5Y)	129.42%	80.81%
Total return CAGR (5Y)	-0.25%	15.93%

Frequently asked

Which has the lower trailing P/E, MELI or OSCR?: OSCR has the lower trailing P/E: MELI trades at 49.75 and OSCR at 21.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, MELI or OSCR?: Over the past five years, OSCR grew revenue faster — MELI at a 44.82% CAGR versus OSCR at 64.83%.
Is MELI or OSCR more profitable?: MELI runs the higher net margin — MELI at 5.30% versus OSCR at 3.60%.
How have MELI and OSCR total returns compared?: Over the past 5 years, MELI delivered 26.94% and OSCR delivered 15.93% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MELI analysis Full OSCR analysis Interactive comparison tool

Dig into the metrics

MercadoLibre P/E ratio Oscar Health P/E ratio MercadoLibre ROE Oscar Health ROE MercadoLibre operating margin Oscar Health operating margin MercadoLibre revenue growth Oscar Health revenue growth MercadoLibre free cash flow Oscar Health free cash flow

MercadoLibre & Oscar Health appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 14, 2026.